Nephro Care India Ltd

Nephro Care Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nephro Care India Ltd

₹ 145 -1.66%
25 Apr - close price
Company website NSE - SME: NEPHROCARE
About

Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes
in the treatment of kidney- related diseases[1]

Key Points

Business Overview:[1][2]
NCIL provides comprehensive medical services for renal patients as a one-stop treatment center in Kolkata. It offers clinical and lifestyle solutions for renal insufficiency, covering lifestyle, physiological, and spiritual wellness. The company specializes in non-invasive services.

Website NSE - SM
  • Market Cap ₹ 239 Cr.
  • Current Price ₹ 145
  • High / Low ₹ 379 / 124
  • Stock P/E 80.9
  • Book Value ₹ 32.1
  • Dividend Yield 0.00 %
  • ROCE 60.4 %
  • ROE 49.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 59.5%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2024 Sep 2024
14.13 17.69
11.41 14.65
Operating Profit 2.72 3.04
OPM % 19.25% 17.18%
0.32 0.47
Interest 0.03 0.06
Depreciation 0.53 0.45
Profit before tax 2.48 3.00
Tax % 69.35% 27.33%
0.76 2.19
EPS in Rs 0.64 1.33
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0.54 1.82 3.42 17.09 27.23 31.82
0.52 1.67 3.28 13.66 20.76 26.06
Operating Profit 0.02 0.15 0.14 3.43 6.47 5.76
OPM % 3.70% 8.24% 4.09% 20.07% 23.76% 18.10%
0.01 0.01 -0.01 0.00 0.28 0.79
Interest 0.04 0.03 0.02 0.07 0.09 0.09
Depreciation 0.00 0.01 0.11 0.78 0.53 0.98
Profit before tax -0.01 0.12 0.00 2.58 6.13 5.48
Tax % 0.00% 25.00% 7.75% 28.06%
-0.01 0.09 -0.01 2.37 4.41 2.95
EPS in Rs -10.00 90.00 -0.20 47.40 3.71 1.97
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 146%
TTM: 59%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 263%
TTM: 82%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 60%
Last Year: 49%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.01 0.01 0.50 0.50 11.90 16.49
Reserves 0.07 0.01 0.00 2.03 3.12 36.46
0.40 0.69 2.54 2.48 0.00 0.00
0.30 0.42 1.60 3.25 5.94 14.21
Total Liabilities 0.78 1.13 4.64 8.26 20.96 67.16
0.45 0.06 1.39 3.01 4.74 5.70
CWIP 0.00 0.45 1.90 0.00 0.86 17.78
Investments 0.24 0.00 0.00 2.00 6.51 25.03
0.09 0.62 1.35 3.25 8.85 18.65
Total Assets 0.78 1.13 4.64 8.26 20.96 67.16

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.23 0.62 4.12 0.91
-0.06 -2.81 -2.33 -7.54
0.28 2.32 -0.08 5.60
Net Cash Flow 0.44 0.13 1.71 -1.03

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 0.00 0.00 20.28 0.85 2.01
Inventory Days 8.83 41.93 35.25 14.07
Days Payable 94.19 113.45 69.03 75.17
Cash Conversion Cycle 0.00 -85.36 -51.24 -32.93 -59.09
Working Capital Days -168.98 -74.20 -117.40 -55.96 -36.86
ROCE % 25.21% 1.60% 65.84% 60.41%

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025
61.38% 61.38% 61.44%
3.92% 4.06% 3.50%
4.82% 3.41% 2.24%
29.87% 31.14% 32.82%
No. of Shareholders 8521,0771,391

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports